Time duration | n (%) | SE (%) | 95% CI |
Lifetime prevalence | 111 (17.0) | 1.47 | 14.1% to 20.0% |
Past 12 months | 19 (2.9) | 0.66 | 1.62% to 4.21% |
*See online supplemental table 3 for domains and indicators used in the estimates.
†The oversampled non-binary participants (n=13) used for a substudy were removed from the analytical sample. Those missing or ‘refused to answer’ in specific screener questions were coded as negative in the corresponding indicators, granted that no participant met the criteria of 40% or more of screener questions missing.